Millions of Americans have successfully lost weight with semaglutides, the game-changing class of drugs that includes Ozempic ...

Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli ...

The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently ...

There has been a seven-fold increase in the number of people using weight loss jabs in the UK over the last year. | ITV News ...

Ozempic, a GLP-1 receptor agonist, has officially launched in India, offering a new treatment option for type 2 diabetes.

A peripherally acting cannabinoid receptor 1 antibody combined with semaglutide induced significant weight loss for adults ...

Danish drugmaker Novo Nordisk has brought its popular weight loss drug Ozempic to India. Check out prices for all doses.

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability ...

Novo Nordisk launches Ozempic in India, outlining prices, doses, and its bid to capture rising diabetes and weight-loss ...

The launch comes amid the company’s legal battle with Indian drugmakers, including Dr Reddy’s Laboratories and Sun Pharma, ...